Sensex Surges Over 450 Points, Nifty Ends Above 17,500 Led by Reliance
Indian equity benchmarks surged on Thursday as November futures and option contracts expired led by gains in index heavyweights like Reliance Industries, Infosys, Kotak Mahindra Bank, HDFC Bank, ITC, Bharti Airtel and Tech Mahindra. The benchmarks opened lower but soon gave up intraday losses with Sensex rising as much as 758 points from the day's lowest level and Nifty 50 reclaimed its important psychological level of 17,500 after hitting an intraday low of 17,351.
The Sensex ended 454Â points higher at 58,795 and Nifty 50 index rose 121Â points to close at 17,536.
"If the Nifty is able to sustain above 17,500, it can go up to 17,600-17,700 levels. The momentum indicators like relative strength index (RSI) and moving averages convergence divergence (MACD) are indicating positive momentum in the market," said Vijay Dhanotiya, lead of technical research at CapitalVia Global Research.
Reliance Industries was the top Nifty gainer, the stock rose over 6 per cent to hit an intraday high of Rs 2,502 after its Board decided to implement a scheme of arrangement to transfer Gasification Undertaking into a wholly-owned subsidiary. Rally in Reliance shares added over 400 points towards gain in the Sensex, data from BSE showed.
Divi's Labs, Infosys, ITC, Dr Reddy's Labs, UPL, Tech Mahindra, HCL Technologies, HCL Technologies, Tata Consumer Products, Cipla and Kotak Mahindra Bank also rose between 0.5-1 per cent.
On the flipside, Hindalco, IndusInd Bank, Axis Bank, Shree Cements, Tata Steel, Mahindra & Mahindra, Bajaj Finance, Eicher Motors, Bharat Petroleum, Bajaj Auto, Larsen & Toubro and Coal India were among the losers.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.